Literature DB >> 21711125

Quality of life trajectory in patients with advanced cancer during the last year of life.

Johannes M Giesinger1, Lisa M Wintner, Anne S Oberguggenberger, Eva M Gamper, Michael Fiegl, Hubert Denz, Georg Kemmler, August Zabernigg, Bernhard Holzner.   

Abstract

INTRODUCTION: Due to the high mortality of cancer a large number of patients pass a preterminal phase of their illness. Within this phase medical care aims at maintaining patients' quality of life (QOL) and reducing symptom burden. Our study investigated the patient-reported severity of QOL impairments during the last year of life, with a special focus on their course at the end of life.
METHODS: All patients with cancer receiving palliative care at Natters State Hospital (Austria) were considered as eligible for the study. QOL data were collected with the EORTC QLQ-C30 questionnaire as part of computerized patient-reported outcome monitoring (ePROM) within clinical routine. QOL was investigated longitudinally in regard to its course toward death as well as to changes in determinants of global QOL.
RESULTS: Eighty-five patients participated in the ePROM (255 assessments in total). Regarding trajectories, physical, role and cognitive functioning, fatigue and global QOL worsened sharply during the last 3 months of life. A steady decline was found for emotional functioning, pain, appetite loss and taste alterations. The impact of role functioning, sleep disturbances, and taste alterations on global QOL increased within the last 3 months of life.
CONCLUSION: Our results indicate that most aspects of QOL are considerably impaired in patients with advanced cancer. Furthermore, they highlight the importance of assessing QOL in general and taste alterations in particular within palliative care.

Entities:  

Mesh:

Year:  2011        PMID: 21711125     DOI: 10.1089/jpm.2011.0086

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  22 in total

1.  Cost-effectiveness of pazopanib in advanced soft-tissue sarcoma in Canada.

Authors:  T E Delea; J Amdahl; H R Nakhaipour; S C Manson; A Wang; N Fedor; A Chit
Journal:  Curr Oncol       Date:  2014-12       Impact factor: 3.677

Review 2.  Hypnosis for Symptom Control in Cancer Patients at the End-of-Life: A Systematic Review.

Authors:  Guy H Montgomery; Madalina Sucala; Tessa Baum; Julie B Schnur
Journal:  Int J Clin Exp Hypn       Date:  2017 Jul-Sep

3.  Palliative care needs of patients with cancer living in the community.

Authors:  Arif H Kamal; Janet Bull; Dio Kavalieratos; Donald H Taylor; William Downey; Amy P Abernethy
Journal:  J Oncol Pract       Date:  2011-11       Impact factor: 3.840

4.  Palliative oncology: identity, progress, and the path ahead.

Authors:  A S Epstein; R S Morrison
Journal:  Ann Oncol       Date:  2012-04       Impact factor: 32.976

5.  Chemotherapy line-associated differences in quality of life in patients with advanced cancer.

Authors:  B Mayrbäurl; L M Wintner; J M Giesinger; Th Himmelfreundpointner; S Burgstaller; B Holzner; J Thaler
Journal:  Support Care Cancer       Date:  2011-12-29       Impact factor: 3.603

6.  Trajectory and predictors of quality of life during the dying process: roles of perceived sense of burden to others and posttraumatic growth.

Authors:  Siew Tzuh Tang; Wen-Cheng Chang; Jen-Shi Chen; Po-Jung Su; Chia-Hsun Hsieh; Wen-Chi Chou
Journal:  Support Care Cancer       Date:  2014-05-28       Impact factor: 3.603

7.  Cost-effectiveness analysis of pazopanib in second-line treatment of advanced soft tissue sarcoma in Spain.

Authors:  G Villa; L J Hernández-Pastor; M Guix; J Lavernia; M Cuesta
Journal:  Clin Transl Oncol       Date:  2014-07-01       Impact factor: 3.405

8.  Health-related quality of life among cancer patients in their last year of life: results from the PROFILES registry.

Authors:  Natasja J H Raijmakers; M Zijlstra; J van Roij; O Husson; S Oerlemans; L V van de Poll-Franse
Journal:  Support Care Cancer       Date:  2018-04-16       Impact factor: 3.603

9.  Self-reported oral health and oral health behaviors in older adults in the last year of life.

Authors:  Xi Chen; Supawadee Naorungroj; Christian E Douglas; James D Beck
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-03-22       Impact factor: 6.053

10.  Cost-effectiveness of zoledronic acid compared with clodronate in multiple myeloma.

Authors:  T E Delea; K El Ouagari; J Rotter; A Wang; S Kaura; G J Morgan
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.